CLINICAL_TRIALS
trial_result
· 2019-02-01
Clinical Trial Update: Gemfibrozil for Nicotine Smoking Cessation [Phase 2]
Summary
A Phase 2 trial testing gemfibrozil for nicotine dependence/smoking cessation has completed and posted results in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Texas Southwestern Medical Center | Conditions: Smoking Cessation | Phase 2 | Status: COMPLETED | Results posted: 2019-02-01